Inhibition of EGFR can improve tyrosine phosphorylation of insulin receptors and insulin receptor substrates in obese mice.[36] EGFR signaling and its downstream pathways provide new therapeutic targets for regulating sleep.[37] Insomnia is a common condition in menopausal women. The gene discussed is EGFR; the disease is insomnia measurement.